Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-... IB Hirsch,B Bode,JP Courreges,... - American Diabetes ...
Palmer JL; Beaudet A; White J;.Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China.Adv Ther.2010.814-827Palmer JL, Beaudet A, White J, et al. Cost‐effectiveness of biphasic insulin aspart versus insulin...
Luzio S, Dunseath G, Peter R, Pauvaday V, Owens DR (2006) Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes. Diabetologia 49:1163-1168.Luzio S, Dunseath G, Peter R, Pauvaday V, Owens DR. Comparison of...